Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
55.9M
-
Shares change
-
-313K
-
Total reported value, excl. options
-
$3.39B
-
Value change
-
-$20.7M
-
Put/Call ratio
-
5.2
-
Number of buys
-
71
-
Number of sells
-
-90
-
Price
-
$60.75
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2018
213 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2018.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.9M shares
of 101M outstanding shares and own 55.33% of the company stock.
Largest 10 shareholders include FMR LLC (8.98M shares), Vanguard Group Inc (6.92M shares), BlackRock Inc. (6.3M shares), Hillhouse Capital Management, Ltd. (2.69M shares), STATE STREET CORP (2.61M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.34M shares), EcoR1 Capital, LLC (2.02M shares), FIRST TRUST ADVISORS LP (1.65M shares), FARALLON CAPITAL MANAGEMENT LLC (1.4M shares), and JANUS HENDERSON GROUP PLC (1.22M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.